BLOOD CANCERS
Clinical trials for BLOOD CANCERS explained in plain language.
Never miss a new study
Get alerted when new BLOOD CANCERS trials appear
Sign up with your email to follow new studies for BLOOD CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cocktail aims to snuff out residual AML before it returns
Disease control Recruiting nowThis study tests a combination of three drugs—tagraxofusp, azacitidine, and venetoclax—in adults with acute myeloid leukemia (AML) who are in remission but still have tiny amounts of cancer cells that standard tests miss. The goal is to see if the combo can safely clear these hid…
Matched conditions: BLOOD CANCERS
Phase: PHASE1, PHASE2 • Sponsor: Jacqueline Garcia, MD • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New tool aims to ensure blood cancer treatments match patient preferences
Knowledge-focused Recruiting nowThis study tests a decision-support tool called PRIME for adults aged 60 and older with blood cancers like leukemia or lymphoma. The tool helps patients clarify their values and shares that information with their doctors. The goal is to see if using PRIME leads to treatment decis…
Matched conditions: BLOOD CANCERS
Phase: NA • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC